Article

Luxottica moves 900 jobs in Cole National merger

Twinsburg, OH-Italian eyewear manufacturing giant Luxottica Group has completed its $495 million acquisition of Cole National Corp. and will close its operation here, moving some of its 900 jobs south to its North American retail headquarters in Cincinnati.

Twinsburg, OH-Italian eyewear manufacturing giant Luxottica Group has completed its $495 million acquisition of Cole National Corp. and will close its operation here, moving some of its 900 jobs south to its North American retail headquarters in Cincinnati.

The company has not said how many of the Cole jobs would be transferred.

"We're looking to move as many as possible," Luxottica spokesman Luca Biondolillo reportedly told the Associated Press.

Cole National also owned personalized gift retailer Things Remembered, with 722 locations throughout the country. Luxottica said that division would be managed separately from the optical business, although observers have speculated that it would be sold.

Luxottica said it intends to combine Cole National's managed vision care business, Cole Managed Vision, with its own EyeMed to make both more competitive in their insurance products.

The Italian manufacturer said it would study other non-store operations, distribution systems, product mix, manufacturing labs, and technology over the next few months before deciding its strategy. The Federal Trade Commission approved the merger in late September. The deal closed Oct. 4, and Cole National shut down the investor relations portion of its Web site. Cole National stockholders will receive $27.72 per share in the transaction.

"The integration of Cole National represents a key step in the strategy for future growth of our group," Leonardo Del Vecchio, Luxottica's chairman, said in a statement. He added that the deal boosts the company's presence in North America. "This is something that has been at the core of our strategy since the acquisition of LensCrafters in 1995."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.